Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 38 publications
Real-world analysis of ctDNA and other biomarkers in patients with curatively resected stage I-III biliary tract cancer.
Journal: ESMO gastrointestinal oncology
Published: August 12, 2026
Circulating Tumor DNA Status and Adjuvant Chemotherapy in Resected Colorectal Liver Metastases.
Journal: JAMA oncology
Published: July 03, 2026
A phase II study of pembrolizumab plus chemotherapy with short-course radiotherapy as induction treatment for unresectable locally advanced esophageal squamous cell carcinoma: PALADIN trial.
Journal: ESMO gastrointestinal oncology
Published: May 28, 2026
Molecular Residual Disease and Recurrence in Rectal Cancer Patients Undergoing Upfront Surgery A Prospective Cohort Study: Erratum.
Journal: Annals of surgery
Published: April 09, 2026
The Landscape of Genomic and Socioeconomic Variables in Patients with Colorectal Cancer Based on Genetic Ancestry.
Journal: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
Published: January 12, 2026
Utility of Circulating Tumor DNA to Assess Tumor Response in Patients with Locally Advanced Rectal Cancer Undergoing Neoadjuvant Therapy.
Journal: Cancers
Published: January 08, 2026
Predictive Role of Circulating Tumor DNA in Stage III Colon Cancer Treated With Celecoxib: A Post Hoc Analysis of the CALGB (Alliance)/SWOG 80702 Phase 3 Randomized Clinical Trial.
Journal: JAMA oncology
Published: December 04, 2025
Preoperative ctDNA and tumor volume predict colorectal cancer recurrence after metastasis resection.
Preoperative ctDNA and tumor volume predict colorectal cancer recurrence after metastasis resection.
Journal: NPJ precision oncology
Published: October 22, 2025
Validation of a methylation-based, tissue-free MRD assay in colorectal cancer patients from the GALAXY study.
Journal: NPJ precision oncology
Published: September 11, 2025
Feasibility of Personalized and Tumor-Informed Circulating Tumor DNA Assay for Early Recurrence Detection in Patients With Hepatocellular Carcinoma.
Journal: JCO precision oncology
Published: July 02, 2025
Last Updated: 09/26/2026